Skip to main content

Advertisement

Log in

Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing

Overall analysis of a female with POR deficiency

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Objective

To characterize the clinical features of a female with P450 oxidoreductase (POR) deficiency and to investigate the underlying mechanisms of POR inactivation.

Methods

The proband was a 35-year-old woman with primary infertility and menstrual irregularity. The reproductive endocrine profile was evaluated. DNA sequencing was conducted for the identification of POR gene mutation. RT-PCR was performed to confirm the impact of the mutation on POR mRNA. A molecular model was built for the structural analysis of mutant POR protein.

Results

The evaluation of reproductive endocrine profile revealed elevation of serum follicle-stimulating hormone (11.48 mIU/ml), progesterone (11.00 ng/ml), 17α-hydroxyprogesterone (24.24 nmol/l), dehydroepiandrosterone (6300 nmol/l), and androstenedione (3.89 nmol/l) and decreased estradiol (36.02 pg/ml). Sequencing of the POR gene showed the female was a compound heterozygote of the paternal P399_E401 deletion and a novel maternal IVS14-1G>C mutation. Functional analysis revealed IVS14-1G>C mutation caused alternative splicing of POR mRNA, with the loss of 12 nucleotides in exon 15 (c.1898_1909delGTCTACGTCCAG). Also, the resulting mutant POR protein had a V603_Q606 deletion, which inactivated the nucleotide-binding domain of NADPH in POR protein (K602_Q606).

Conclusion

The mutation IVS14-1G>C of the POR gene could cause alternative splicing of POR mRNA and dysfunction of the resulting POR protein. Under proper IVF strategy with glucocorticoid therapy and endometrial preparation, females with mild POR deficiency still have the opportunity to have a live birth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Miller WL. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology. 2005;146(6):2544–50.

    Article  CAS  Google Scholar 

  2. Ono T, Bloch K. Solubilization and partial characterization of rat liver squalene epoxidase. J Biol Chem. 1975;250(4):1571–9.

    PubMed  CAS  Google Scholar 

  3. Ilan Z, Ilan R, Cinti DL. Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system. J Biol Chem. 1981;256(19):10066–72.

  4. Wilks A, Black SM, Miller WL, Ortiz de Montellano PR. Expression and characterization of truncated human heme oxygenase (hHO-1) and a fusion protein of hHO-1 with human cytochrome P450 reductase. Biochemistry. 1995;34(13):4421–7.

    Article  CAS  Google Scholar 

  5. Harry GE, Philipp S. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J Biol Chem. 1979;254(18):8976–81.

    Google Scholar 

  6. Wang M, Roberts DL, Paschke R, Shea TM, Masters BS, Kim JJ. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci U S A. 1997;94(16):8411–6.

    Article  CAS  Google Scholar 

  7. Ellis J, Gutierrez A, Barsukov IL, Huang WC, Grossmann JG, Roberts GC. Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering. J Biol Chem. 2009;284(52):36628–37.

    Article  CAS  Google Scholar 

  8. Scott RR, Gomes LG, Huang N, Van Vliet G, Miller WL. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2007;92(6):2318–22.

    Article  CAS  Google Scholar 

  9. Shen AL, O'Leary KA, Kasper CB. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem. 2002;277(8):6536–41.

    Article  CAS  Google Scholar 

  10. Otto DME, Henderson CJ, Carrie D, Davey M, Gundersen TE, Blomhoff R, et al. Identification of novel roles of the cytochrome P450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol Cell Biol. 2003;23(17):6103–16.

  11. Sahakitrungruang T, Huang N, Tee MK, Agrawal V, Russell WE, Crock P, et al. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab. 2009;94(12):4992–5000.

    Article  CAS  Google Scholar 

  12. Fluck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet. 2004;36(3):228–30.

    Article  CAS  Google Scholar 

  13. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet. 2005;76(5):729–49.

    Article  CAS  Google Scholar 

  14. Fluck CE, Nicolo C, Pandey AV. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase. Fundam Clin Pharmacol. 2007;21(4):399–410.

    Article  CAS  Google Scholar 

  15. Hershkovitz E, Parvari R, Wudy SA, Hartmann MF, Gomes LG, Loewental N, et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab. 2008;93(9):3584–8.

  16. Song T, Wang B, Chen H, Zhu J, Sun H. In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report. Gynecol Endocrinol. 2018;34(5):385–8.

  17. Papadakis GE, Dumont A, Bouligand J, Chasseloup F, Raggi A, Catteau-Jonard S, et al. Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations. Hum Reprod. 2020;35(4):939–49.

    Article  Google Scholar 

  18. Huang B, Hu D, Qian K, Ai J, Li Y, Jin L, et al. Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles. Fertil Steril. 2014;102(5):1345–9.

    Article  Google Scholar 

  19. Huang B, Ren X, Wu L, Zhu L, Xu B, Li Y, et al. Elevated progesterone levels on the day of oocyte maturation may affect top quality embryo IVF cycles. PLoS One. 2016;11(1):e0145895.

    Article  CAS  Google Scholar 

  20. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–303.

    Article  CAS  Google Scholar 

  21. Rutledge LR, Campbell-Verduyn LS, Wetmore SD. Characterization of the stacking interactions between DNA or RNA nucleobases and the aromatic amino acids. Chem Phys Lett. 2007;444(1–3):167–75.

    Article  CAS  Google Scholar 

  22. Rahman MM, Muhseen ZT, Junaid M, Zhang H. The aromatic stacking interactions between proteins and their macromolecular ligands. Curr Protein Pept Sci. 2015;16(6):502–12.

    Article  CAS  Google Scholar 

  23. Scott RR, Miller WL. Genetic and clinical features of p450 oxidoreductase deficiency. Horm Res. 2008;69(5):266–75.

    Article  CAS  Google Scholar 

  24. Styer AK, Jackson KV, Hornstein MD, Racowsky C, Ginsburg ES, Gargiulo AR. Pregnancy outcomes in in vitro fertilization cycles with serum estradiol drop prior to human chorionic gonadotropin. Int J Gynecol Obstet. 2005;89(2):133–7.

  25. Huang R, Fang C, Wang N, Li L, Yi Y, Liang X. Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles. Eur J Obstet Gynecol Reprod Biol. 2014;178:177–82.

    Article  CAS  Google Scholar 

  26. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, et al. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod. 2009;24(11):2902–9.

    Article  CAS  Google Scholar 

  27. Zavy MT, Craig LB, Wild RA, Kahn SN, O'Leary D, Hansen KR. In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol : RB&E. 2014;12:119.

    Article  CAS  Google Scholar 

  28. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012;27(9):2690–7.

    Article  CAS  Google Scholar 

  29. Melnick AP, Pereira N, Murphy EM, Rosenwaks Z, Spandorfer SD. How low is too low? Cycle day 28 estradiol levels and pregnancy outcomes. Fertil Steril. 2016;105(4):905–9 e901.

    Article  CAS  Google Scholar 

  30. Araki S, Chikazawa K, Sekiguchi I, Yamauchi H, Motoyama M, Tamada T. Arrest of follicular development in a patient with 17 alpha-hydroxylase deficiency: folliculogenesis in association with a lack of estrogen synthesis in the ovaries. Fertil Steril. 1987;47(1):169–72.

    Article  CAS  Google Scholar 

  31. Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, et al. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod BioMed Online. 2012;24(5):511–20.

    Article  CAS  Google Scholar 

  32. Taskin EA, Atabekoglu CS, Musali N, Oztuna D, Sonmezer M. Association of serum estradiol levels on the day of hCG administration with pregnancy rates and embryo scores in fresh ICSI/ET cycles down regulated with either GnRH agonists or GnRH antagonists. Arch Gynecol Obstet. 2014;289(2):399–405.

    Article  CAS  Google Scholar 

  33. Wang M, Hao C, Bao H, Huang X, Liu Z, Zhang W, et al. Effect of elevated estradiol levels on the hCG administration day on IVF pregnancy and birth outcomes in the long GnRH-agonist protocol: analysis of 3393 cycles. Arch Gynecol Obstet. 2017;295(2):407–14.

  34. Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril. 2012;97(6):1321–1327 e1321-1324.

    Article  CAS  Google Scholar 

  35. Bu Z, Zhao F, Wang K, Guo Y, Su Y, Zhai J, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS One. 2014;9(6):e100011.

    Article  CAS  Google Scholar 

  36. Huang Y, Wang EY, Du QY, Xiong YJ, Guo XY, Yu YP, et al. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages. Reprod Biol Endocrinol : RB&E. 2015;13:82.

    Article  CAS  Google Scholar 

  37. Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015;30(3):684–91.

    Article  CAS  Google Scholar 

  38. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092–100.

    Article  CAS  Google Scholar 

  39. Bry-Gauillard H, Meduri G, Abirached F, Constancis E, Brailly S, Chanson P, et al. Primary amenorrhea revealing an occult progesterone-secreting ovarian tumor. Fertil Steril. 2008;90(4):1198 e1191–5.

    Article  Google Scholar 

  40. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19(5):433–57.

  41. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet. 2004;363(9427):2128–35.

    Article  CAS  Google Scholar 

  42. Fluck CE, Mallet D, Hofer G, Samara-Boustani D, Leger J, Polak M, et al. Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency. Biochem Biophys Res Commun. 2011;412(4):572–7.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank everyone in the department of Reproductive Medicine in the Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology (HUST) for their scientific advice and encouragement.

Conflict of interest

The authors declare that they have no competing interests.

Funding

This work was supported by the research grants from:

1. National Key Research and Development Program (China, 2018YFC1002103)

2. The Chinese Medical Association (16020520668)

3. The Natural Science Foundation of Hubei Province (China, 2017CFB752)

Author information

Authors and Affiliations

Authors

Contributions

Tao Zhang carried out the analysis and interpretation of data and writing of the manuscript. Zhou Li, Bo Huang, and Xinling Ren have been involved in the ultrasound examination and critical manuscript revisions. Lei Jin and Guijin Zhu participated in its design and coordination and helped to draft the manuscript. Wei Yang participated in the conception and design of the study. All authors have read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Wei Yang or Lei Jin.

Ethics declarations

The study protocol was approved by the Medical Ethics Committee of Tongji Hospital. Written informed consent was obtained from all participants. Research was conducted according to the Declaration of Helsinki for medical research.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Précis

Clinical and genetic analysis of POR deficiency in a female.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, T., Li, Z., Ren, X. et al. Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing. J Assist Reprod Genet 37, 2503–2511 (2020). https://doi.org/10.1007/s10815-020-01899-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-020-01899-z

Keywords

Navigation